Free Trial

Inovio Pharmaceuticals (INO) Institutional Ownership

Inovio Pharmaceuticals logo
$1.15 +0.06 (+5.50%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$1.14 -0.01 (-0.87%)
As of 10/9/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Inovio Pharmaceuticals (NASDAQ:INO)

Current
Institutional Ownership
Percentage
26.79%
Number of
Institutional Buyers
(last 12 months)
33
Total
Institutional Inflows
(last 12 months)
$17.62M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$5.04M
Get INO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inovio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

INO Institutional Buying and Selling by Quarter

Inovio Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/8/2026Green Alpha Advisors LLC114,857$140K0.1%+68.8%0.111%
9/9/2026Engineers Gate Manager LP33,691$37K0.0%N/A0.033%
9/9/2026Squarepoint Ops LLC36,391$40K0.0%+46.5%0.035%
8/20/2026Headlands Technologies LLC29,889$33K0.0%N/A0.029%
5/19/2026Bank of America Corp DE32,677$57K0.0%-50.3%0.040%
5/18/2026ADAR1 Capital Management LLC1,470,108$2.56M0.2%-5.8%1.787%
5/18/2026Eversept Partners LP1,035,360$1.80M0.1%N/A1.258%
5/14/2026Renaissance Technologies LLC643,777$1.12M0.0%+16.4%0.927%
3/3/2026Caitong International Asset Management Co. Ltd48,948$85K0.0%+1,929.4%0.073%
2/23/2026Virtu Financial LLC44,040$77K0.0%N/A0.066%
2/18/2026XTX Topco Ltd167,037$291K0.0%-20.7%0.250%
2/18/2026Millennium Management LLC1,403,379$2.44M0.0%-28.9%2.103%
2/18/2026Janus Henderson Group PLC3,308,406$5.77M0.0%+1.3%4.958%
2/18/2026Bridgeway Capital Management LLC173,000$301K0.0%N/A0.259%
2/18/2026683 Capital Management LLC248,790$433K0.0%N/A0.373%
2/17/2026Adage Capital Partners GP L.L.C.2,553,571$4.44M0.0%-25.5%3.827%
2/16/2026OMERS ADMINISTRATION Corp223,000$388K0.0%N/A0.334%
2/13/2026Marshall Wace LLP82,331$143K0.0%N/A0.123%
2/13/2026Hudson Bay Capital Management LP50,677$88K0.0%N/A0.076%
2/13/2026State Street Corp247,410$430K0.0%+32.9%0.371%
2/13/2026Caitong International Asset Management Co. Ltd20,572$36K0.1%+752.9%0.031%
2/12/2026Renaissance Technologies LLC553,164$963K0.0%-32.2%0.829%
2/12/2026CIBC Private Wealth Group LLC50,000$87K0.0%+357,042.9%0.075%
2/11/2026LPL Financial LLC18,613$32K0.0%-28.4%0.028%
2/10/2026Goldman Sachs Group Inc.27,288$47K0.0%-49.2%0.041%
2/9/2026Geode Capital Management LLC769,356$1.34M0.0%+40.7%1.153%
2/6/2026GSA Capital Partners LLP459,828$800K0.1%+3.8%0.689%
2/5/2026Baader Bank Aktiengesellschaft36,767$64K0.0%N/A0.055%
1/29/2026Concurrent Investment Advisors LLC36,011$63K0.0%-35.7%0.054%
1/7/2026Green Alpha Advisors LLC72,095$125K0.1%+49.9%0.108%
1/1/2026JPMorgan Chase & Co.65,206$153K0.0%+1,667.1%0.098%
11/17/2025Jacobs Levy Equity Management Inc.17,673$41K0.0%N/A0.026%
11/17/2025XTX Topco Ltd210,567$493K0.0%+855.5%0.316%
11/17/2025Qube Research & Technologies Ltd33,496$78K0.0%-70.9%0.050%
11/17/2025Millennium Management LLC1,972,518$4.62M0.0%+468.7%2.956%
11/17/2025Focus Partners Wealth14,289$33K0.0%N/A0.021%
11/17/2025Boxer Capital Management LLC2,300,000$5.38M1.7%N/A3.447%
11/17/2025Bank of America Corp DE636,061$1.49M0.0%-49.9%1.187%
11/14/2025Zacks Investment Management19,455$46K0.0%N/A0.036%
11/14/2025Raymond James Financial Inc.16,680$39K0.0%+4,396.0%0.031%
No. 1 stock to cash in on the death of iPhone (Ad)

Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel

Get the free ticker and see Baylin's full research now
11/14/2025Two Sigma Investments LP290,800$680K0.0%+299.9%0.543%
11/13/2025UBS Group AG293,062$686K0.0%+46.8%0.551%
11/7/2025GSA Capital Partners LLP443,104$1.04M0.1%+171.4%0.834%
11/7/2025Vanguard Group Inc.2,712,872$6.35M0.0%+35.0%5.105%
11/7/2025JPMorgan Chase & Co.65,206$153K0.0%+1,667.1%0.123%
11/5/2025MCF Advisors LLC11,274$26K0.0%N/A0.021%
10/27/2025Stephens Inc. AR13,500$32K0.0%N/A0.025%
10/23/2025SG Americas Securities LLC11,497$27K0.0%N/A0.022%
10/15/2025Green Alpha Advisors LLC48,088$113K0.1%-9.8%0.090%
8/15/2025Bank of America Corp DE1,270,607$2.59M0.0%-2.6%3.465%
8/14/2025Jane Street Group LLC39,683$81K0.0%+221.2%0.108%
8/14/2025Qube Research & Technologies Ltd115,164$234K0.0%N/A0.314%
8/12/2025XTX Topco Ltd22,038$45K0.0%-66.7%0.060%
8/12/2025Catalyst Funds Management Pty Ltd17,000$35K0.0%N/A0.046%
8/8/2025Geode Capital Management LLC437,549$891K0.0%-48.3%1.193%
8/5/2025Bank of Montreal Can57,946$118K0.0%+23.7%0.158%
8/1/2025Y Intercept Hong Kong Ltd42,171$86K0.0%N/A0.115%
8/1/2025Green Alpha Advisors LLC53,308$108K0.1%-13.0%0.145%
7/23/2025Prime Capital Investment Advisors LLC20,372$41K0.0%-32.8%0.056%
6/27/2025Goldman Sachs Group Inc.130,534$213K0.0%-55.1%0.356%
5/16/2025Goldman Sachs Group Inc.130,534$213K0.0%-55.1%0.356%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,781$34K0.0%+39.6%0.057%
5/16/2025AQR Capital Management LLC73,575$120K0.0%N/A0.201%
5/15/2025Nomura Holdings Inc.16,871$28K0.0%N/A0.046%
5/14/2025Freedom Investment Management Inc.19,170$31K0.0%N/A0.052%
5/14/2025Stonepine Capital Management LLC518,331$845K0.8%-50.6%1.413%
5/12/2025Nuveen LLC103,297$168K0.0%N/A0.282%
5/9/2025Deutsche Bank AG39,025$64K0.0%-56.6%0.106%
5/9/2025Charles Schwab Investment Management Inc.98,495$161K0.0%+38.6%0.269%
5/8/2025XTX Topco Ltd66,169$108K0.0%+26.7%0.180%
4/29/2025Concurrent Investment Advisors LLC55,011$90K0.0%N/A0.150%
4/29/2025Bank of New York Mellon Corp75,422$123K0.0%+22.4%0.206%
2/18/2025Alpine Global Management LLC16,906$31K0.0%N/A0.065%
2/17/2025Stonepine Capital Management LLC1,050,000$1.92M1.6%N/A4.023%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC225,000$412K0.0%N/A0.862%
2/17/2025Graham Capital Management L.P.62,567$114K0.0%N/A0.240%
2/17/2025Deutsche Bank AG89,864$164K0.0%+524.6%0.344%
2/17/2025Deep Track Capital LP3,119,162$5.71M0.2%+72.9%11.951%
2/17/2025Bank of America Corp DE640,987$1.17M0.0%+1,035.2%2.456%
2/14/2025Jane Street Group LLC39,704$73K0.0%+118.2%0.152%
2/14/2025Northern Trust Corp219,057$401K0.0%+6.4%0.839%
2/14/2025Boothbay Fund Management LLC24,000$44K0.0%N/A0.092%
2/14/2025Susquehanna Fundamental Investments LLC65,669$120K0.0%N/A0.252%
2/14/2025Alpine Global Management LLC16,906$31K0.0%N/A0.065%
2/14/2025Dimensional Fund Advisors LP79,079$145K0.0%-39.4%0.303%
2/13/2025XTX Topco Ltd52,230$96K0.0%N/A0.200%
2/13/2025Barclays PLC39,114$71K0.0%+15.0%0.150%
2/13/2025Renaissance Technologies LLC242,305$443K0.0%-26.8%0.928%
2/13/2025Bank of Montreal Can23,495$43K0.0%N/A0.090%
2/12/2025Geode Capital Management LLC628,505$1.15M0.0%+1.1%2.408%
No. 1 stock to cash in on the death of iPhone (Ad)

Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel

Get the free ticker and see Baylin's full research now
2/12/2025AIGH Capital Management LLC654,115$1.20M0.4%N/A2.506%
2/12/2025Highbridge Capital Management LLC300,000$549K0.0%N/A1.149%
2/3/2025Wolverine Asset Management LLC97,400$178K0.0%N/A0.373%
1/13/2025Green Alpha Advisors LLC65,446$120K0.1%+103.2%0.251%
11/19/2024Barclays PLC34,003$197K0.0%+282.6%0.130%
11/16/2024Geode Capital Management LLC621,631$3.59M0.0%+6.7%2.395%
11/15/2024Barclays PLC34,003$197K0.0%+282.6%0.131%
11/15/2024Jane Street Group LLC18,192$105K0.0%-17.4%0.070%
11/15/2024Wellington Management Group LLP65,633$379K0.0%N/A0.253%
11/15/2024State Street Corp490,662$2.84M0.0%+11.7%1.890%


INO Institutional Ownership - Frequently Asked Questions

During the previous two years, 71 institutional investors and hedge funds held shares of Inovio Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($6.35M), Janus Henderson Group PLC ($5.77M), Deep Track Capital LP ($5.71M), Boxer Capital Management LLC ($5.38M), Adage Capital Partners GP L.L.C. ($4.44M), ADAR1 Capital Management LLC ($2.56M), and Millennium Management LLC ($2.44M).Learn more on Inovio Pharmaceuticals' institutional investors.

26.79% of Inovio Pharmaceuticals' stock is owned by institutional investors. Learn more on INO's institutional investor holdings.

Of the 65 institutional investors that purchased Inovio Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Boxer Capital Management LLC ($2.30M), Millennium Management LLC ($1.63M), Deep Track Capital LP ($1.31M), Stonepine Capital Management LLC ($1.05M), Eversept Partners LP ($1.04M), Vanguard Group Inc. ($703.73K), and AIGH Capital Management LLC ($654.12K).

Institutional investors have bought a total of 8,224,120 shares in the last 24 months. This purchase volume represents approximately $17.62M in transactions.

Of the 11 institutional investors that sold Inovio Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($875K), Bank of America Corp DE ($667.66K), Millennium Management LLC ($569.14K), Renaissance Technologies LLC ($263.18K), ADAR1 Capital Management LLC ($90.40K), Qube Research & Technologies Ltd ($81.67K), and XTX Topco Ltd ($43.53K).

Institutional investors have sold a total of 2,649,592 shares in the last 24 months. This volume of shares sold represents approximately $5.04M in transactions.



Institutional ownership data for NASDAQ:INO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/8/2026. New 13F filings are added each quarter as they're published.
From Our Partners